Peter Marks has over 35 years’ experience in corporate advisory, investment banking and director/advisory roles to the Board. With several leading firms, Peter’s corporate skills lie in deal origination & structuring, capital raising for pre-IPO as well as listed companies, cross border M&A transactions, corporate underwriting, and venture capital transactions for companies in Australia, US & Israel. Peter’s current ASX directorships are Iris Metals Ltd, Evergreen Lithium Ltd, Alterity Therapeutics Ltd (previously Prana Biotechnology Ltd (listed on NASDAQ and ASX), and Noxopharm Ltd. He is also on the Board of Electriq~Global an unlisted public company which is looking to list on ASX during 2023.
Please note, the topics and stocks discussed in this podcast are not financial or investment advice.
Follow the Market bull:
Website - www.themarketbull.com.au
If you have a topic you want us to discuss or want to be a potential guest on the show make sure to email us on our website.
